info:eu-repo/semantics/article
Going Forward with Lymphocytes Immunotherapies for Treatment of Unexplained Recurrent Spontaneous Abortion
Fecha
2019-12Registro en:
Arana, Eloisa; Fernandez, Pablo Mariano; Going Forward with Lymphocytes Immunotherapies for Treatment of Unexplained Recurrent Spontaneous Abortion; BiomedGrid ; American Journal of American Journal of Biomedical Science & Research; 6; 5; 12-2019; 368-369
2642-1747
CONICET Digital
CONICET
Autor
Arana, Eloisa
Fernandez, Pablo Mariano
Resumen
Recurrent spontaneous abortion (RSA), defined as the occurrence of two or more consecutive miscarriages at less than 22-weeks of gestation [1], is one of the major pregnancy disorders and affects up to 5% of couples of reproductive ages. Although genetic factors, hormonal diseases, anatomical anomalies and antiphospholipid syndrome have been linked with RSA [2,3], 50% of cases still remain unexplained and generate growing interest to unveil potential involved mechanism, particularly for those that imply immunological pathways